Cargando…

NK Cell Development in Times of Innate Lymphoid Cell Diversity

After being described in the 1970s as cytotoxic cells that do not require MHC-dependent pre-activation, natural killer (NK) cells remained the sole member of innate lymphocytes for decades until lymphoid tissue-inducer cells in the 1990s and helper-like innate lymphoid lineages from 2008 onward comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokic-Trtica, Vladislava, Diefenbach, Andreas, Klose, Christoph S. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360798/
https://www.ncbi.nlm.nih.gov/pubmed/32733432
http://dx.doi.org/10.3389/fimmu.2020.00813
_version_ 1783559283015680000
author Stokic-Trtica, Vladislava
Diefenbach, Andreas
Klose, Christoph S. N.
author_facet Stokic-Trtica, Vladislava
Diefenbach, Andreas
Klose, Christoph S. N.
author_sort Stokic-Trtica, Vladislava
collection PubMed
description After being described in the 1970s as cytotoxic cells that do not require MHC-dependent pre-activation, natural killer (NK) cells remained the sole member of innate lymphocytes for decades until lymphoid tissue-inducer cells in the 1990s and helper-like innate lymphoid lineages from 2008 onward completed the picture of innate lymphoid cell (ILC) diversity. Since some of the ILC members, such as ILC1s and CCR6(−) ILC3s, share specific markers previously used to identify NK cells, these findings provoked the question of how to delineate the development of NK cell and helper-like ILCs and how to properly identify and genetically interfere with NK cells. The description of eomesodermin (EOMES) as a lineage-specifying transcription factor of NK cells provided a candidate that may serve as a selective marker for the genetic targeting and identification of NK cells. Unlike helper-like ILCs, NK cell activation is, to a large degree, regulated by the engagement of activating and inhibitory surface receptors. NK cell research has revealed some elegant mechanisms of immunosurveillance, coined “missing-self” and “induced-self” recognition, thus complementing “non-self recognition”, which is predominantly utilized by adaptive lymphocytes and myeloid cells. Notably, the balance of activating and inhibitory signals perceived by surface receptors can be therapeutically harnessed for anti-tumor immunity mediated by NK cells. This review aims to summarize the similarities and the differences in development, function, localization, and phenotype of NK cells and helper-like ILCs, with the purpose to highlight the unique feature of NK cell development and regulation.
format Online
Article
Text
id pubmed-7360798
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73607982020-07-29 NK Cell Development in Times of Innate Lymphoid Cell Diversity Stokic-Trtica, Vladislava Diefenbach, Andreas Klose, Christoph S. N. Front Immunol Immunology After being described in the 1970s as cytotoxic cells that do not require MHC-dependent pre-activation, natural killer (NK) cells remained the sole member of innate lymphocytes for decades until lymphoid tissue-inducer cells in the 1990s and helper-like innate lymphoid lineages from 2008 onward completed the picture of innate lymphoid cell (ILC) diversity. Since some of the ILC members, such as ILC1s and CCR6(−) ILC3s, share specific markers previously used to identify NK cells, these findings provoked the question of how to delineate the development of NK cell and helper-like ILCs and how to properly identify and genetically interfere with NK cells. The description of eomesodermin (EOMES) as a lineage-specifying transcription factor of NK cells provided a candidate that may serve as a selective marker for the genetic targeting and identification of NK cells. Unlike helper-like ILCs, NK cell activation is, to a large degree, regulated by the engagement of activating and inhibitory surface receptors. NK cell research has revealed some elegant mechanisms of immunosurveillance, coined “missing-self” and “induced-self” recognition, thus complementing “non-self recognition”, which is predominantly utilized by adaptive lymphocytes and myeloid cells. Notably, the balance of activating and inhibitory signals perceived by surface receptors can be therapeutically harnessed for anti-tumor immunity mediated by NK cells. This review aims to summarize the similarities and the differences in development, function, localization, and phenotype of NK cells and helper-like ILCs, with the purpose to highlight the unique feature of NK cell development and regulation. Frontiers Media S.A. 2020-07-08 /pmc/articles/PMC7360798/ /pubmed/32733432 http://dx.doi.org/10.3389/fimmu.2020.00813 Text en Copyright © 2020 Stokic-Trtica, Diefenbach and Klose. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Stokic-Trtica, Vladislava
Diefenbach, Andreas
Klose, Christoph S. N.
NK Cell Development in Times of Innate Lymphoid Cell Diversity
title NK Cell Development in Times of Innate Lymphoid Cell Diversity
title_full NK Cell Development in Times of Innate Lymphoid Cell Diversity
title_fullStr NK Cell Development in Times of Innate Lymphoid Cell Diversity
title_full_unstemmed NK Cell Development in Times of Innate Lymphoid Cell Diversity
title_short NK Cell Development in Times of Innate Lymphoid Cell Diversity
title_sort nk cell development in times of innate lymphoid cell diversity
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360798/
https://www.ncbi.nlm.nih.gov/pubmed/32733432
http://dx.doi.org/10.3389/fimmu.2020.00813
work_keys_str_mv AT stokictrticavladislava nkcelldevelopmentintimesofinnatelymphoidcelldiversity
AT diefenbachandreas nkcelldevelopmentintimesofinnatelymphoidcelldiversity
AT klosechristophsn nkcelldevelopmentintimesofinnatelymphoidcelldiversity